181 related articles for article (PubMed ID: 37458065)
1. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
[TBL] [Abstract][Full Text] [Related]
2. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.
Battistini C; Kenny HA; Zambuto M; Nieddu V; Melocchi V; Decio A; Lo Riso P; Villa CE; Gatto A; Ghioni M; Porta FM; Testa G; Giavazzi R; Colombo N; Bianchi F; Lengyel E; Cavallaro U
Cell Death Dis; 2024 May; 15(5):370. PubMed ID: 38806454
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
[TBL] [Abstract][Full Text] [Related]
7. Notum enhances gastric cancer stem-like cell properties through upregulation of Sox2 by PI3K/AKT signaling pathway.
Liu Y; Chen H; Xiao L; Dong P; Ma Y; Zhou Y; Yang J; Bian B; Xie G; Chen L; Shen L
Cell Oncol (Dordr); 2024 Apr; 47(2):463-480. PubMed ID: 37749430
[TBL] [Abstract][Full Text] [Related]
8. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
[TBL] [Abstract][Full Text] [Related]
9. AKT1 phosphorylates RBM17 to promote Sox2 transcription by modulating alternative splicing of FOXM1 to enhance cancer stem cell properties in colorectal cancer cells.
Fu Y; Bai C; Wang S; Chen D; Zhang P; Wei H; Rong F; Zhang C; Chen S; Wang Z
FASEB J; 2023 Jan; 37(1):e22707. PubMed ID: 36520054
[TBL] [Abstract][Full Text] [Related]
10. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
11. The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells.
Cao X; Liu L; Cao X; Cui Y; Zou C; Chen A; Qiu Y; Quan M; Ren K; Chen X; Cao J
J Oncol; 2020; 2020():8978930. PubMed ID: 32308683
[TBL] [Abstract][Full Text] [Related]
12. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated FOXM1 signaling in the regulation of cancer stem cells.
Sher G; Masoodi T; Patil K; Akhtar S; Kuttikrishnan S; Ahmad A; Uddin S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):107-121. PubMed ID: 35931301
[TBL] [Abstract][Full Text] [Related]
14. FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway.
Wang L; Mao X; Yu X; Su J; Li Z; Chen Z; Ren Y; Huang H; Wang W; Zhao C; Hu Y
Cancer Lett; 2024 Jul; 593():216841. PubMed ID: 38614385
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer.
Modi A; Purohit P; Roy D; Vishnoi JR; Pareek P; Elhence P; Singh P; Sharma S; Sharma P; Misra S
Mol Biol Rep; 2022 Apr; 49(4):2877-2888. PubMed ID: 35066766
[TBL] [Abstract][Full Text] [Related]
18. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1.
Chen A; Xu C; Luo Y; Liu L; Song K; Deng G; Yang M; Cao J; Yuan L; Li X
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1267-1275. PubMed ID: 31750892
[TBL] [Abstract][Full Text] [Related]
19. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
20. DDX56 promotes EMT and cancer stemness via MELK-FOXM1 axis in hepatocellular carcinoma.
Li Q; Wang T; Wang X; Ge X; Yang T; Wang W
iScience; 2024 Jun; 27(6):109827. PubMed ID: 38827395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
